You may remember last year’s campaign led by Brooke Shields.  This year, the campaign is led by lifestyle designer Kathy Ireland, professional ballroom dancer Chelsie Hightower and style guide Bobbie Thomas.

“With approximately 1.5 million bottles sold since launching the product a little more than a year ago, LATISSE is giving back by helping the Make-A-Wish Foundation grant the wishes of children. Through the campaign, we will double each individual’s donation, with a maximum donation of $250,000, through October 31,” said Robert Grant, President of Allergan Medical, a division of Allergan, Inc.

Read more about purchasing Latisse in Tulsa, Oklahoma

What doctors labeled a ‘complication’ or side effect of using these topical agents was “hypertrichosis,” a condition characterized by darkening, thickening, and lengthening of the eyelashes.   

 Allergan offered the topical prostaglandin Lumigan in 2001, a drug that contained the active ingredient bimatoprost. Two important precursors to Latisse occurred after the FDA gave clearance for Lumigan.

• Jan Marini Skin Research Inc had over $2 million worth of product seized by the Food and Drug Administration.  The product, Age Intervention Eyelash, evidently contained bimatoprost, which was unapproved for cosmetic use at the time. Allergan later filed a patent infringement suit against Jan Marini and several other companies that had tried to market bimatoprost in their eyelash enhancing drugs.
• Some doctors started prescribing Lumigan off-label to enhance eyelashes.  Knowing the desirable side effects it could produce. But Lumigan wasn’t formulated for cosmetic use and many believed more research was needed to confirm the safety of topical prostaglandins for cosmetic use.  

Clinical trials and further research is exactly what Alllergan Inc did.  In one early study, 278 healthy adults with minimal to moderate eyelash prominence applied bimatoprost or a placebo to their lash line.  The results were favorable; researchers observed that the average patient’s eyelashes were 25 percent longer, 106 percent fuller, and 18 percent darker, while only 3.6 percent experienced itchy eyes and redness, and only 2.9 percent experienced skin hyperpigmentation.  

Latisse received FDA approval late last year for the treatment of ‘inadequate’ eyelashes.  Allergan now owns the patent on use of bimatoprost for eyelash enhancement.

Contact us for more information on Latisse in Tulsa, Oklahoma.

This clip is from a recent episode of ‘The Doctors‘ featuring dermatologist Jessica Wu and Allergan’s new eyelash enhancement drug, Latisse.

Latisse can give you “crazy long spidery lashes” in just 4 months, says Dr. Wu. You apply Latisse to the base of the upper eyelashes once each night, “just like liquid eyeliner.” The results should yield lashes that are 25 percent longer and 100 percent thicker!

See the video for a before & after photo; it is quite impressive. If you are interested in learning more about Latisse in Oklahoma, call or email our office.

At a red carpet Hollywood event March 27th, Brooke Shields, Mandy Moore, Marisa Tomei, and other big name celebrities were in attendance to support Allergan’s new Latisse Wishes campaign.

The campaign aims to raise money for the Make-A-Wish foundation, and will generate interest in Allergan’s new eyelash enhancement drug. A $500,000 initial contribution to Make-A-Wish was announced at the event.

Latisse is the first drug to be approved by the FDA for the treatment of hypotrichosis (inadequate eyelashes). When applied to the base of the upper eyelids, it stimulates the growth of thicker, darker lashes.

Beauty expert and participant, Anastasia Soare, enthusiastically expressed her support, saying “I constantly work to help make women’s beauty wishes come true, and now we can help children’s wishes come true through the LATISSE™ Wishes campaign.”

It isn’t a mere coincidence that the Make-A-Wish foundation was the chosen beneficiary; the superstitious tradition of “blowing on an eyelash to make a wish come true” provides a clever marketing strategy, now backed by philanthropy.

Allergan is encouraging consumers to help increase the donation amount by visiting www.Latisse.com and registering their support. From now until the end of the year, the company will donate 5 dollars for each new registration, up to one million dollars.

Latisse is now available at our office in Tulsa; give us a call for more information.